203 related articles for article (PubMed ID: 23465347)
1. Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation.
Conde D; Costabel JP; Aragon M; Caro M; Ferro A; Klein A; Trivi M; Giniger A
Can J Cardiol; 2013 Oct; 29(10):1330.e13. PubMed ID: 23465347
[No Abstract] [Full Text] [Related]
2. Conversion of recent onset atrial fibrillation: which drug is faster?
Conde D
Am J Emerg Med; 2013 Sep; 31(9):1410-1. PubMed ID: 23796978
[No Abstract] [Full Text] [Related]
3. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?
Conde D
Int J Cardiol; 2013 Oct; 169(2):95-6. PubMed ID: 24071384
[TBL] [Abstract][Full Text] [Related]
4. Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
Conde D; Costabel JP; Aragon M; Lambardi F; Klein A; Corrales Barbosa A; Trivi M; Giniger A
Cardiovasc Ther; 2013 Dec; 31(6):377-80. PubMed ID: 23683253
[TBL] [Abstract][Full Text] [Related]
5. Vernakalant hydrochloride to treat atrial fibrillation.
Brown RA; Lau YC; Lip GY
Expert Opin Pharmacother; 2014 Apr; 15(6):865-72. PubMed ID: 24617913
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.
Bash LD; Buono JL; Davies GM; Martin A; Fahrbach K; Phatak H; Avetisyan R; Mwamburi M
Cardiovasc Drugs Ther; 2012 Apr; 26(2):167-79. PubMed ID: 22418856
[TBL] [Abstract][Full Text] [Related]
7. Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation.
Conde D; Costabel JP; Caro M; Ferro A; Lambardi F; Corrales Barboza A; Lavalle Cobo A; Trivi M
Int J Cardiol; 2013 Oct; 168(3):2423-5. PubMed ID: 23518212
[TBL] [Abstract][Full Text] [Related]
8. A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalant.
Vizzardi E; Salghetti F; Bonadei I; Gelsomino S; Lorusso R; D'Aloia A; Curnis A
Cardiovasc Ther; 2013 Oct; 31(5):e55-62. PubMed ID: 23398692
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
Romano S; Fattore L; Toscano G; Corsini F; Coppo A; Catanzaro M; Romano A; Martone A; Caccavale F; Iodice E; Di Maggio O; Corsini G
Ital Heart J Suppl; 2001 Jan; 2(1):41-5. PubMed ID: 11216083
[TBL] [Abstract][Full Text] [Related]
10. Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion.
Enriquez A; Conde D; Hopman W; Mondragon I; Chiale PA; de Luna AB; Baranchuk A
Cardiovasc Ther; 2014 Apr; 32(2):52-6. PubMed ID: 24417765
[TBL] [Abstract][Full Text] [Related]
11. Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation.
Conde D; Costabel JP; Aragon M; Lambardi F; Trivi M
Cardiol J; 2014; 21(3):304-8. PubMed ID: 23990184
[TBL] [Abstract][Full Text] [Related]
12. Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat.
Camm AJ; Savelieva I
BMJ; 2007 Mar; 334(7594):637. PubMed ID: 17379911
[No Abstract] [Full Text] [Related]
13. Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines.
Savelieva I; Graydon R; Camm AJ
Europace; 2014 Feb; 16(2):162-73. PubMed ID: 24108230
[TBL] [Abstract][Full Text] [Related]
14. [Propafenone, flecainide, procainamide in the treatment of a fresh attack of atrial fibrillation].
Kosmala W; Kucharski W; Haczyński J; Kobusiak-Prokopowicz M
Wiad Lek; 1994; 47(21-24):801-7. PubMed ID: 8999690
[TBL] [Abstract][Full Text] [Related]
15. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation].
Hinneburg I
Med Monatsschr Pharm; 2011 May; 34(5):154-8. PubMed ID: 21644373
[TBL] [Abstract][Full Text] [Related]
16. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G
N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of vernakalant vs flecainide for cardioversion of atrial fibrillation in the emergency department: the VERITA study.
Dominijanni G; Caballero-Bermejo AF; Martín Jiménez ML; Calpe Delgado P; Rodríguez-Miranda B; Ruiz-Antorán B
Emergencias; 2024 Jun; 36(3):239-240. PubMed ID: 38819000
[No Abstract] [Full Text] [Related]
18. Recent-onset atrial fibrillation in patients with left ventricular dysfunction: amiodarone or vernakalant?
Conde D; Costabel JP; Alves de Lima A
Can J Cardiol; 2013 Oct; 29(10):1330.e11-1330.e12. PubMed ID: 23639270
[No Abstract] [Full Text] [Related]
19. Management of patients with acute atrial fibrillation in the ED.
Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
[TBL] [Abstract][Full Text] [Related]
20. Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: clue to specificity of Brugada-type electrocardiographic changes.
Beldner S; Lin D; Marchlinski FE
Am J Cardiol; 2004 Nov; 94(9):1184-5. PubMed ID: 15518618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
